Congenital Heart Disease GEnetic NEtwork Study (CHD GENES)
| Status: | Recruiting | 
|---|---|
| Conditions: | Cardiology | 
| Therapuetic Areas: | Cardiology / Vascular Diseases | 
| Healthy: | No | 
| Age Range: | Any - 99 | 
| Updated: | 1/27/2019 | 
| Start Date: | November 2010 | 
| End Date: | July 2020 | 
| Contact: | Eileen King, PhD | 
| Email: | Eileen.King@cchmc.org | 
| Phone: | 513-803-1819 | 
Congenital heart defects (CHD) are the most common major human birth malformation, affecting
~8 per 1,000 live births. CHD are associated with significant morbidity and mortality, and
are second only to infectious diseases in contributing to the infant mortality rate. Current
understanding of the etiology of pediatric cardiovascular disorders is limited.
The Congenital Heart Disease GEnetic NEtwork Study (CHD GENES) is a multi-center, prospective
observational cohort study. Participants will be recruited from the Pediatric Cardiac
Genomics Consortium's (PCGC) centers of the NHLBI-sponsored Bench to Bassinet (B2B) Program.
Biological specimens will be obtained for genetic analyses, and phenotype data will be
collected by interview and from medical records. State-of-the-art genomic technologies will
be used to identify common genetic causes of CHD and genetic modifiers of clinical outcome.
To accomplish this, the PCGC will develop and maintain a biorepository of specimens (DNA) and
genetic data, along with detailed, phenotypic and clinical outcomes data in order to
investigate relationships between genetic factors and phenotypic and clinical outcomes in
congenital heart disease.
			~8 per 1,000 live births. CHD are associated with significant morbidity and mortality, and
are second only to infectious diseases in contributing to the infant mortality rate. Current
understanding of the etiology of pediatric cardiovascular disorders is limited.
The Congenital Heart Disease GEnetic NEtwork Study (CHD GENES) is a multi-center, prospective
observational cohort study. Participants will be recruited from the Pediatric Cardiac
Genomics Consortium's (PCGC) centers of the NHLBI-sponsored Bench to Bassinet (B2B) Program.
Biological specimens will be obtained for genetic analyses, and phenotype data will be
collected by interview and from medical records. State-of-the-art genomic technologies will
be used to identify common genetic causes of CHD and genetic modifiers of clinical outcome.
To accomplish this, the PCGC will develop and maintain a biorepository of specimens (DNA) and
genetic data, along with detailed, phenotypic and clinical outcomes data in order to
investigate relationships between genetic factors and phenotypic and clinical outcomes in
congenital heart disease.
Inclusion Criteria:
• Signed consent form
Exclusion Criteria:
- Isolated patent foramen ovale
- Isolated prematurity-associated patent ductus arteriosus
We found this trial at
    13
    sites
	Click here to add this to my saved trials
	 
  
									75 Francis street
Boston, Massachusetts 02115
	
			Boston, Massachusetts 02115
(617) 732-5500 
							 
					Principal Investigator: Christine Seidman, MD
			
						
										Phone: 617-432-1006
					
		Brigham and Women's Hosp Boston’s Brigham and Women’s Hospital (BWH) is an international leader in...  
  
  Click here to add this to my saved trials
	 
  
									4650 Sunset Blvd
Los Angeles, California 90027
	
			Los Angeles, California 90027
 (323) 660-2450 
							 
					Principal Investigator: Richard W Kim, MD
			
						
										Phone: 323-361-1912
					
		Childrens Hospital Los Angeles Children's Hospital Los Angeles is a 501(c)(3) nonprofit hospital for pediatric...  
  
  Click here to add this to my saved trials
	 
  
									South 34th Street
Philadelphia, Pennsylvania 19104
	
			Philadelphia, Pennsylvania 19104
 215-590-1000 
							 
					Principal Investigator: Elizabeth Goldmuntz, MD
			
						
										Phone: 215-590-1473
					
		Children's Hospital of Philadelphia Since its start in 1855 as the nation's first hospital devoted...  
  
  Click here to add this to my saved trials
	 
  
									60 Crittenden Blvd # 70
Rochester, New York 14642
	
			Rochester, New York 14642
(585) 275-2121 
							 
					Principal Investigator: George A Porter, MD, PHD
			
						
										Phone: 585-273-4168
					
		University of Rochester The University of Rochester is one of the country's top-tier research universities....  
  
  Click here to add this to my saved trials
	 
  
									201 Presidents Circle
Salt Lake City, Utah 84108
	
			Salt Lake City, Utah 84108
801) 581-7200 
							 
					Principal Investigator: Martin Tristani-Firouzi, MD
			
						
										Phone: 801-587-8975
					
		University of Utah Research is a major component in the life of the U benefiting...  
  
  Click here to add this to my saved trials
	 
  
								Boston, Massachusetts 02115			
	
			
					Principal Investigator: Amy Roberts, MD
			
						
										Phone: 617-355-4979
					Click here to add this to my saved trials
	 
  
								New Haven, Connecticut 6520			
	
			(203) 432-4771 
							 
					Principal Investigator: Martina Brueckner, MD
			
						
										Phone: 203-737-6835
					
		Yale University Yale's roots can be traced back to the 1640s, when colonial clergymen led...  
  
  Click here to add this to my saved trials
	 
  Click here to add this to my saved trials
	 
  
								New York, New York 10029			
	
			
					Principal Investigator: Bruce Gelb, MD
			
						
										Phone: 212-241-4321
					Click here to add this to my saved trials
	 
  
									630 W 168th St
New York, New York
	
			New York, New York
212-305-2862 
							 
					Principal Investigator: Wendy K Chung, MD, PHD
			
						
										Phone: 212-342-3101
					
		Columbia University Medical Center Situated on a 20-acre campus in Northern Manhattan and accounting for...  
  
  Click here to add this to my saved trials
	 
  
								Palo Alto, California 94304			
	
			
					Principal Investigator: Daniel Bernstein, MD
			
						
										Phone: 650-724-4661
					Click here to add this to my saved trials
	 
  Click here to add this to my saved trials
	